ZYVOX

This brand name is authorized in Brazil, Ecuador, Hong Kong, Ireland, Japan, Malta, New Zealand, Singapore, United Kingdom, United States

Active ingredients

The drug ZYVOX contains one active pharmaceutical ingredient (API):

1 Linezolid UNII ISQ9I6J12J - LINEZOLID

Linezolid is a synthetic, antibacterial agent that belongs to a new class of antimicrobials, the oxazolidinones. It has in vitro activity against aerobic Gram-positive bacteria and anaerobic micro-organisms. Linezolid selectively inhibits bacterial protein synthesis via a unique mechanism of action. Read about Linezolid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYVOX Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX08	Linezolid	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718080081617, 522718080081717
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 23.641-1-04-11, 548-MEE-1214
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44504, 48274, 49470
Country: HK	Department of Health Drug Office	Identifier(s): 48055, 48056, 48057
Country: IE	Health Products Regulatory Authority	Identifier(s): 88361, 88362
Country: JP	医薬品医療機器総合機構	Identifier(s): 6249002F1024, 6249401A1025
Country: MT	Medicines Authority	Identifier(s): MA505/01802, MA505/01803
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9578, 9579, 9581
Country: SG	Health Sciences Authority	Identifier(s): 11405P, 11407P, 11408P
Country: US	FDA, National Drug Code	Identifier(s): 0009-4992, 0009-5136, 0009-5137, 0009-5138, 0009-5140, 0009-7807, 66298-4992, 66298-5137, 66298-5140, 66298-7807, 70518-1226